Researchers recommend investigating adipocytokines, neuroinflammation, and biomarkers such as GFAP and NfL in metabolism-related disorders like T2D and obesity to clarify their roles independent of amyloid and tau pathology [24]. This evidence concerns the gene GFAP and obesity disorder.